A citation-based method for searching scientific literature

Eric Pujade-Lauraine, Felix Hilpert, B√©atrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard. J Clin Oncol 2014
Times Cited: 766



Alison Davis, Anna V Tinker, Michael Friedlander. Gynecol Oncol 2014
Times Cited: 169




List of shared articles



Times cited

Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine.
Yoshifumi Takahashi, Yuji Takei, Shizuo Machida, Akiyo Taneichi, Suzuyo Takahashi, Takahiro Yoshiba, Takahiro Koyanagi, Kohei Tamura, Yasushi Saga, Hiroyuki Fujiwara. J Obstet Gynaecol Res 2021
1

A source of hope for platinum-resistant ovarian cancer?
Sarah P Blagden, Shibani Nicum. Lancet 2021
1

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
K N Moore, A M Oza, N Colombo, A Oaknin, G Scambia, D Lorusso, G E Konecny, S Banerjee, C G Murphy, J L Tanyi,[...]. Ann Oncol 2021
4

Creation and validation of models to predict response to primary treatment in serous ovarian cancer.
Jesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, Brian J Smith, David P Bender, Michael J Goodheart, Megan E McDonald, Terry A Braun, Kristina W Thiel, Kimberly K Leslie. Sci Rep 2021
2

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment.
Mark A Eckert, Carlos Orozco, Jason Xiao, Melissa Javellana, Ernst Lengyel. Cancers (Basel) 2021
0

Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.
Claudia Marchetti, Francesca De Felice, Alessia Romito, Valentina Iacobelli, Carolina Maria Sassu, Giacomo Corrado, Caterina Ricci, Giovanni Scambia, Anna Fagotti. Semin Cancer Biol 2021
1

CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.
Mayu Shiomi, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Chihiro Mizuta-Odani, Mariko Jitsumori, Ruriko Nakae, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu,[...]. Cancer Sci 2021
1